OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions
Nicholas J. Short, Elias Jabbour, Nitin B. Jain, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Nicholas J. Short, Elias Jabbour, Nitin B. Jain, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Showing 6 citing articles:
How to use monoclonal antibody-based therapy in ALL
Erica Brivio, Sujith Samarasinghe
EJC Paediatric Oncology (2025), pp. 100214-100214
Open Access
Erica Brivio, Sujith Samarasinghe
EJC Paediatric Oncology (2025), pp. 100214-100214
Open Access
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin
Jayastu Senapati, Elias Jabbour, Nicholas J. Short, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Jayastu Senapati, Elias Jabbour, Nicholas J. Short, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Recent Developments and Evolving Therapeutic Strategies in KMT2A ‐Rearranged Acute Leukemia
Lei Yin, Lin Wan, Youjian Zhang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 20
Open Access | Times Cited: 1
Lei Yin, Lin Wan, Youjian Zhang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 20
Open Access | Times Cited: 1
CD58 expression does not impact response to inotuzumab ozogamicin in patients with B‐cell acute lymphoblastic leukemia
Rafael Madero‐Marroquin, Ryan W. Hunter, Caner Saygin, et al.
eJHaem (2024) Vol. 6, Iss. 1
Open Access
Rafael Madero‐Marroquin, Ryan W. Hunter, Caner Saygin, et al.
eJHaem (2024) Vol. 6, Iss. 1
Open Access
Inotuzumab Ozogamicin in Indian Patients with B-Cell Acute Lymphoblastic Leukemia
Pronamee Borah, Vivek Mohan, Sachin Jain, et al.
Indian Journal of Hematology and Blood Transfusion (2024)
Closed Access
Pronamee Borah, Vivek Mohan, Sachin Jain, et al.
Indian Journal of Hematology and Blood Transfusion (2024)
Closed Access
Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy
Rositsa Mihaylova, Denitsa Momekova, Viktoria Elincheva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1701-1701
Open Access
Rositsa Mihaylova, Denitsa Momekova, Viktoria Elincheva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1701-1701
Open Access
